Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT01995123 |
Date of registration:
|
20/11/2013 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Behavioral Activation for Smoking Cessation in PTSD
|
Scientific title:
|
Behavioral Activation for Smoking Cessation in Veterans With PTSD |
Date of first enrolment:
|
September 8, 2014 |
Target sample size:
|
124 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT01995123 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Investigator, Outcomes Assessor).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
Jessica M Cook, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
William S. Middleton Memorial Veterans Hospital, Madison, WI |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Report smoking an average of 10 or more cigarettes daily for at least six months
- Report a desire to quit smoking
- Meet criteria for current PTSD
- Speak and read English
- Agree to participate in the study
- Be 18 years old
- Be a veteran
Exclusion Criteria:
- Meeting criteria for psychotic or bipolar disorder
- Psychoactive substance abuse or dependence (excluding nicotine dependence) within the
past 6 months
- Inability to give informed, voluntary, written consent to participate
- Current use of any pharmacotherapy for smoking cessation not provided by the
researchers during the quit attempt
- Use of non-cigarette tobacco products as a primary form of tobacco use
- Being currently suicidal or homicidal
- Being medically unable to use the nicotine patch or nicotine gum/lozenge
- Psychotropic medication changes within 3 months of study initiation and during active
treatment
- Current engagement in evidence-based therapies for PTSD or depression
- Pregnant or trying to become pregnant
- Incarceration
Age minimum:
18 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Tobacco Dependence
|
PTSD
|
Intervention(s)
|
Behavioral: Health and Smoking Education
|
Behavioral: Behavioral Activation Therapy
|
Behavioral: Standard Smoking Cessation Therapy
|
Primary Outcome(s)
|
Percentage of Participants Who Abstained From Smoking
[Time Frame: 26 weeks post target quit date]
|
Secondary Outcome(s)
|
Clinician Administered PTSD Scale Score
[Time Frame: 4 weeks post target quit date (end of treatment)]
|
Time to Smoking Relapse
[Time Frame: 26 weeks post target quit date]
|
Secondary ID(s)
|
MHBA-002-12F
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
|